Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Report

China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 24, 2022
  • PAGES：220
  • REPORT CODE：GMM1142879
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astellas Pharma US, Inc

    • Pfizer Inc

    • GlaxoSmithKline

    • Johnson & Johnson

    • AstraZeneca

    • Seqirus

    • Emergent BioSolutions Inc

    • Novartis AG

    • Sanofi Pasteur

    • Protein Sciences Corporation

    • Lanzhou Institute of Biological Products Co, Ltd

    • Merck Sharp & Dohme Corp

    By Type:

    • Immune DTaP Vaccine

    • Therapy DTaP Vaccine

    By End-User:

    • Adult

    • Pediatric

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Immune DTaP Vaccine from 2016 to 2027

    • 1.3.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Therapy DTaP Vaccine from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Adult from 2016 to 2027

    • 1.4.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Pediatric from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Major Types

    • 3.4.1 Market Size and Growth Rate of Immune DTaP Vaccine

    • 3.4.2 Market Size and Growth Rate of Therapy DTaP Vaccine

    4 Segmentation of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in Adult

    • 4.4.2 Market Size and Growth Rate of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in Pediatric

    5 Market Analysis by Regions

    • 5.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Analysis by Regions

    • 5.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis

    • 6.1 North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major Types

    • 6.2 North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major End-Users

    7 Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis

    • 7.1 Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major Types

    • 7.2 Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major End-Users

    8 South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis

    • 8.1 South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major Types

    • 8.2 South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major End-Users

    9 East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis

    • 9.1 East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major Types

    • 9.2 East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major End-Users

    10 Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis

    • 10.1 Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major Types

    • 10.2 Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major End-Users

    11 Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis

    • 11.1 Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major Types

    • 11.2 Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major End-Users

    12 Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis

    • 12.1 Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major Types

    • 12.2 Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Astellas Pharma US, Inc

      • 13.1.1 Astellas Pharma US, Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Pfizer Inc

      • 13.2.1 Pfizer Inc Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 GlaxoSmithKline

      • 13.3.1 GlaxoSmithKline Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Johnson & Johnson

      • 13.4.1 Johnson & Johnson Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 AstraZeneca

      • 13.5.1 AstraZeneca Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Seqirus

      • 13.6.1 Seqirus Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Emergent BioSolutions Inc

      • 13.7.1 Emergent BioSolutions Inc Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Novartis AG

      • 13.8.1 Novartis AG Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sanofi Pasteur

      • 13.9.1 Sanofi Pasteur Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Protein Sciences Corporation

      • 13.10.1 Protein Sciences Corporation Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Lanzhou Institute of Biological Products Co, Ltd

      • 13.11.1 Lanzhou Institute of Biological Products Co, Ltd Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Merck Sharp & Dohme Corp

      • 13.12.1 Merck Sharp & Dohme Corp Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Immune DTaP Vaccine from 2016 to 2027

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Therapy DTaP Vaccine from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Adult from 2016 to 2027

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size and Growth Rate of Pediatric from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Immune DTaP Vaccine

    • Figure Market Size and Growth Rate of Therapy DTaP Vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Adult

    • Figure Market Size and Growth Rate of Pediatric

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Regions

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Regions

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Regions in 2016

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Regions in 2021

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Regions in 2027

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Regions

    • Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Regions

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Regions in 2016

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Regions in 2021

    • Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Regions in 2027

    • Table North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Types from 2016 to 2027

    • Table North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types from 2016 to 2027

    • Figure North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2016

    • Figure North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2021

    • Figure North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2027

    • Table North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by End-Users from 2016 to 2027

    • Table North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2016

    • Figure North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2021

    • Figure North China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2027

    • Table Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Types from 2016 to 2027

    • Table Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2016

    • Figure Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2021

    • Figure Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2027

    • Table Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by End-Users from 2016 to 2027

    • Table Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2016

    • Figure Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2021

    • Figure Central China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2027

    • Table South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Types from 2016 to 2027

    • Table South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2016

    • Figure South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2021

    • Figure South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2027

    • Table South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by End-Users from 2016 to 2027

    • Table South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2016

    • Figure South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2021

    • Figure South China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2027

    • Table East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Types from 2016 to 2027

    • Table East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types from 2016 to 2027

    • Figure East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2016

    • Figure East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2021

    • Figure East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2027

    • Table East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by End-Users from 2016 to 2027

    • Table East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2016

    • Figure East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2021

    • Figure East China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2027

    • Table Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2016

    • Figure Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2021

    • Figure Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2027

    • Table Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2027

    • Table Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Types from 2016 to 2027

    • Table Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2016

    • Figure Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2021

    • Figure Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2027

    • Table Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2016

    • Figure Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2021

    • Figure Southwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2027

    • Table Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Types from 2016 to 2027

    • Table Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2016

    • Figure Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2021

    • Figure Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by Types in 2027

    • Table Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2016

    • Figure Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2021

    • Figure Northwest China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Astellas Pharma US, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma US, Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma US, Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma US, Inc

    • Table Product and Service Introduction of Astellas Pharma US, Inc

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Seqirus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seqirus

    • Figure Sales and Growth Rate Analysis of Seqirus

    • Figure Revenue and Market Share Analysis of Seqirus

    • Table Product and Service Introduction of Seqirus

    • Table Company Profile and Development Status of Emergent BioSolutions Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions Inc

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions Inc

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions Inc

    • Table Product and Service Introduction of Emergent BioSolutions Inc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Sanofi Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur

    • Table Product and Service Introduction of Sanofi Pasteur

    • Table Company Profile and Development Status of Protein Sciences Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein Sciences Corporation

    • Figure Sales and Growth Rate Analysis of Protein Sciences Corporation

    • Figure Revenue and Market Share Analysis of Protein Sciences Corporation

    • Table Product and Service Introduction of Protein Sciences Corporation

    • Table Company Profile and Development Status of Lanzhou Institute of Biological Products Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanzhou Institute of Biological Products Co, Ltd

    • Figure Sales and Growth Rate Analysis of Lanzhou Institute of Biological Products Co, Ltd

    • Figure Revenue and Market Share Analysis of Lanzhou Institute of Biological Products Co, Ltd

    • Table Product and Service Introduction of Lanzhou Institute of Biological Products Co, Ltd

    • Table Company Profile and Development Status of Merck Sharp & Dohme Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Sharp & Dohme Corp

    • Figure Sales and Growth Rate Analysis of Merck Sharp & Dohme Corp

    • Figure Revenue and Market Share Analysis of Merck Sharp & Dohme Corp

    • Table Product and Service Introduction of Merck Sharp & Dohme Corp


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US